Aeovian Pharmaceuticals Raises $55 Million to Advance First-in-Class Selective mTORC1 Inhibitor for Tuberous Sclerosis ...
A combination of missed prevention opportunities and health inequalities can result in the early deaths of people living with ...
Wigan Today on MSN
A Wigan mum has spoken out about her five-year-old son's medical treatment after he was diagnosed with lung damage
A mum is looking into taking legal action against Wigan Infirmary over the care given to her young son. Leah Anders, from ...
The British Medical Association (BMA) has announced strike action by resident doctors from 7am on Wednesday 17 December 2025 until 7am on Monday 22 December 2025. While other NHS staff will still be ...
Encoded Therapeutics Inc. ("Encoded"), a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced the appointment of Dr. Joseph Sullivan M.D ...
TipRanks on MSN
Lipocine advances phase 3 trial for PPD treatment
Lipocine ( ($LPCN) ) has shared an announcement. On December 16, 2025, Lipocine announced that its Phase 3 clinical trial for LPCN 1154, an oral ...
Epilepsy is when the brain has an electrical misfire that causes multiple seizures. And depending on where the misfire takes place, the seizure will have different effects, such as freezing you or ...
There are at least 500 sudden and unexpected deaths in the city each year, and in roughly a fifth of those cases, a genetic ...
Researchers identify GRIN2A as a rare single-gene cause of early psychiatric disorders, with symptoms often beginning in ...
The best weight loss medication for men includes semaglutide (Ozempic , Wegovy ), tirzepatide (Mounjaro , Zepbound ), and ...
Stockhead on MSN
Health Check: No longer sheepish, Opthea flags fresh start
After its disastrous phase III eye disease trials, Opthea will repurpose its lead asset to treat a rare lung disease the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback